The environment within: How gut microbiota may influence metabolism and body composition

Diabetologia

Volumn 53, Issue 4, 2010, Pages 606-613

  Vrieze, A ^a   Holleman, F ^a   Zoetendal, E G ^b   De Vos, W M ^b,c   Hoekstra, J B L ^a   Nieuwdorp, M ^a,d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Gut microbiota; Insulin resistance; Obesity; Review; Type 2 diabetes

Indexed keywords

ADIPONECTIN; ANTIBIOTIC AGENT; BUTYRIC ACID; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; NEUROTRANSMITTER;

BODY COMPOSITION; BODY WEIGHT; DIET; ENVIRONMENTAL FACTOR; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTESTINE FLORA; KNOCKOUT MOUSE; LIPID DIET; LIPID STORAGE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ATHEROSCLEROSIS; BACTERIA; BODY COMPOSITION; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIET; DIGESTION; ENERGY METABOLISM; HUMANS; INTESTINES; OBESITY; PHYLOGENY; PREVALENCE;

EID: 77949265935     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1662-7     Document Type: Review

References (64)

1. H Tilg AR Moschen A Kaser 2009 Obesity and the microbiota Gastroenterology 136 1476 1483 10.1053/j.gastro.2009.03.030 19327360
2. JK DiBaise H Zhang MD Crowell R Krajmalnik-Brown GA Decker BE Rittmann 2008 Gut microbiota and its possible relationship with obesity Mayo Clin Proc 83 460 469 10.4065/83.4.460 18380992
3. SH Duncan GE Lobley G Holtrop, et al. 2008 Human colonic microbiota associated with diet, obesity and weight loss Int J Obes (Lond) 32 1720 1724 10.1038/ijo.2008.155 1:STN:280:DC%2BD1cjktFGjuw%3D%3D
4. F Guarner JR Malagelada 2003 Gut flora in health and disease Lancet 361 512 519 10.1016/S0140-6736(03)12489-0 12583961 (Pubitemid 36173720)
5. RH Eckel SM Grundy PZ Zimmet 2005 The metabolic syndrome Lancet 365 1415 1428 10.1016/S0140-6736(05)66378-7 1:CAS:528:DC%2BD2MXjsVegtbg%3D 15836891 (Pubitemid 40523737)
6. J Tuomilehto J Lindstrom JG Eriksson, et al. 2001 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 344 1343 1350 10.1056/NEJM200105033441801 1:STN:280:DC%2BD3M3kvFejsA%3D%3D 11333990 (Pubitemid 32378388)
7. R Taylor 2008 Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause Diabetologia 51 1781 1789 10.1007/s00125-008-1116-7 1:CAS:528:DC%2BD1cXhtVOnur3O 18726585
8. JO Hill JC Peters 1998 Environmental contributions to the obesity epidemic Science 280 1371 1374 10.1126/science.280.5368.1371 1:CAS:528:DyaK1cXjtlagsLc%3D 9603719 (Pubitemid 28264817)
9. NA Christakis JH Fowler 2007 The spread of obesity in a large social network over 32 years N Engl J Med 357 370 379 10.1056/NEJMsa066082 1:CAS:528:DC%2BD2sXotFChtb0%3D 17652652 (Pubitemid 47124137)
10. PJ Turnbaugh M Hamady T Yatsunenko, et al. 2009 A core gut microbiome in obese and lean twins Nature 457 480 484 10.1038/nature07540 1:CAS:528: DC%2BD1MXotlOlsw%3D%3D 19043404
11. L Dethlefsen M Fall-Ngai DA Relman 2007 An ecological and evolutionary perspective on human-microbe mutualism and disease Nature 449 811 818 10.1038/nature06245 1:CAS:528:DC%2BD2sXhtFOjt7nM 17943117 (Pubitemid 47598621)
12. J Xu JI Gordon 2003 Inaugural article: honor thy symbionts Proc Natl Acad Sci USA 100 10452 10459 10.1073/pnas.1734063100 1:CAS:528:DC%2BD3sXntFyns7k%3D 12923294 (Pubitemid 37071899)
13. EG Zoetendal EE Vaughan WM de Vos 2006 A microbial world within us Mol Microbiol 59 1639 1650 10.1111/j.1365-2958.2006.05056.x 1:CAS:528: DC%2BD28Xjslaktbc%3D 16553872
14. EG Zoetendal AD Akkermans WM de Vos 2001 The host genotype affects the bacterial community in the human gastrointestinal tract Microb Ecol Health Dis 13 129 134 10.1080/089106001750462669 (Pubitemid 32905860)
15. HJ Harmsen AC Wildeboer-Veloo GC Raangs, et al. 2000 Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods J Pediatr Gastroenterol Nutr 30 61 67 10.1097/00005176-200001000-00019 1:STN:280:DC%2BD3c%2FpsVWgtQ%3D%3D 10630441 (Pubitemid 30349947)
16. CF Favier EE Vaughan WM de Vos AD Akkermans 2002 Molecular monitoring of succession of bacterial communities in human neonates Appl Environ Microbiol 68 219 226 10.1128/AEM.68.1.219-226.2002 1:CAS:528:DC%2BD38Xjt1Wntw%3D%3D 11772630 (Pubitemid 34031183)
17. K Orrhage CE Nord 1999 Factors controlling the bacterial colonization of the intestine in breastfed infants Acta Paediatr Suppl 88 47 57 1:STN:280:DC%2BD3c%2FjsVGisw%3D%3D 10569223
18. C Palmer EM Bik DB Digiulio DA Relman PO Brown 2007 Development of the human infant intestinal microbiota PLoS Biol 5 1556 1573 10.1371/journal.pbio. 0050177 1:CAS:528:DC%2BD2sXps1anu70%3D
19. RE Ley PJ Turnbaugh S Klein JI Gordon 2006 Microbial ecology: human gut microbes associated with obesity Nature 444 1022 1023 10.1038/4441022a 1:CAS:528:DC%2BD28XhtlemtLvM 17183309 (Pubitemid 46018512)
20. EG Zoetendal AD Akkermans WM de Vos 1998 Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria Appl Environ Microbiol 64 3854 3859 1:CAS:528:DyaK1cXms1entLY%3D 9758810
21. L Dethlefsen S Huse ML Sogin DA Relman 2008 The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing PLoS Biol 6 2383 2400 10.1371/journal.pbio.0060280 1:CAS:528:DC%2BD1cXhsVOgs7vM
22. F Backhed H Ding T Wang, et al. 2004 The gut microbiota as an environmental factor that regulates fat storage Proc Natl Acad Sci USA 101 15718 15723 10.1073/pnas.0407076101 15505215 (Pubitemid 39473554)
23. PJ Turnbaugh RE Ley MA Mahowald V Magrini ER Mardis JI Gordon 2006 An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444 1027 1031 10.1038/nature05414 17183312 (Pubitemid 46018515)
24. F Backhed RE Ley JL Sonnenburg DA Peterson JI Gordon 2005 Host-bacterial mutualism in the human intestine Science 307 1915 1920 10.1126/science.1104816 15790844 (Pubitemid 40404694)
25. F Backhed JK Manchester CF Semenkovich JI Gordon 2007 Mechanisms underlying the resistance to diet-induced obesity in germ-free mice Proc Natl Acad Sci USA 104 979 984 10.1073/pnas.0605374104 1:CAS:528:DC%2BD2sXhtVSitbo%3D 17210919 (Pubitemid 46154722)
26. BS Samuel A Shaito T Motoike, et al. 2008 Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41 Proc Natl Acad Sci USA 105 16767 16772 10.1073/pnas.0808567105 1:CAS:528:DC%2BD1cXhtlersrvP 18931303
27. RE Ley F Backhed P Turnbaugh CA Lozupone RD Knight JI Gordon 2005 Obesity alters gut microbial ecology Proc Natl Acad Sci USA 102 11070 11075 10.1073/pnas.0504978102 1:CAS:528:DC%2BD2MXnvVWju7g%3D 16033867 (Pubitemid 41105994)
28. PJ Turnbaugh F Backhed L Fulton JI Gordon 2008 Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome Cell Host Microbe 3 213 223 10.1016/j.chom.2008.02.015 1:CAS:528: DC%2BD1cXmtlejur0%3D 18407065
29. I Nadal A Santacruz A Marcos, et al. 2008 Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents Int J Obes (Lond) 33 758 767 10.1038/ijo.2008.260
30. H Zhang JK DiBaise A Zuccolo, et al. 2009 Human gut microbiota in obesity and after gastric bypass Proc Natl Acad Sci USA 106 2365 2370 10.1073/pnas.0812600106 1:CAS:528:DC%2BD1MXit12jtL4%3D 19164560
31. A Schwiertz D Taras K Schafer, et al. 2010 Microbiota and SCFA in lean and overweight healthy subjects Obesity (Silver Spring) 18 190 195 10.1038/oby.2009.167
32. M Kalliomaki MC Collado S Salminen E Isolauri 2008 Early differences in fecal microbiota composition in children may predict overweight Am J Clin Nutr 87 534 538 1:CAS:528:DC%2BD1cXjsVagt7w%3D 18326589
33. GS Hotamisligil 2006 Inflammation and metabolic disorders Nature 444 860 867 10.1038/nature05485 1:CAS:528:DC%2BD28XhtlShtrzK 17167474 (Pubitemid 46024993)
34. PD Cani NM Delzenne 2007 Gut microflora as a target for energy and metabolic homeostasis Curr Opin Clin Nutr Metab Care 10 729 734 10.1097/MCO.0b013e3282efdebb 18089955 (Pubitemid 350293774)
35. PD Cani J Amar MA Iglesias, et al. 2007 Metabolic endotoxaemia initiates obesity and insulin resistance Diabetes 56 1761 1772 10.2337/db06-1491 1:CAS:528:DC%2BD2sXnvVWjurk%3D 17456850 (Pubitemid 47025442)
36. M Membrez F Blancher M Jaquet, et al. 2008 Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice FASEB J 22 2416 2426 10.1096/fj.07-102723 1:CAS:528:DC%2BD1cXotlGntL8%3D 18326786 (Pubitemid 351948659)
37. PD Cani AM Neyrinck F Fava, et al. 2007 Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia Diabetologia 50 2374 2383 10.1007/s00125-007-0791-0 1:CAS:528:DC%2BD2sXhtFSlsLzP 17823788 (Pubitemid 47512397)
38. E Vice JD Privette RC Hickner HA Barakat 2005 Ketone body metabolism in lean and obese women Metabolism 54 1542 1545 10.1016/j.metabol.2005.05.023 1:CAS:528:DC%2BD2MXhtFKmu7%2FO 16253646 (Pubitemid 41527027)
39. MD Saemann GA Bohmig CH Osterreicher, et al. 2000 Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production FASEB J 14 2380 2382 1:CAS:528: DC%2BD3MXht1Sntrs%3D 11024006
40. JP Segain BD de la Raingeard A Bourreille, et al. 2000 Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease Gut 47 397 403 10.1136/gut.47.3.397 1:CAS:528:DC%2BD3cXmsFOhtb8%3D 10940278 (Pubitemid 30670835)
41. MA Vinolo E Hatanaka RH Lambertucci P Newsholme R Curi 2009 Effects of short chain fatty acids on effector mechanisms of neutrophils Cell Biochem Funct 27 48 55 10.1002/cbf.1533 1:CAS:528:DC%2BD1MXhsVCmsLg%3D 19107872
42. P Louis KP Scott SH Duncan HJ Flint 2007 Understanding the effects of diet on bacterial metabolism in the large intestine J Appl Microbiol 102 1197 1208 10.1111/j.1365-2672.2007.03322.x 1:CAS:528:DC%2BD2sXmslKgur4%3D 17448155 (Pubitemid 46633434)
43. MA Mahowald FE Rey H Seedorf, et al. 2009 Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla Proc Natl Acad Sci USA 106 5859 5864 10.1073/pnas.0901529106 1:CAS:528: DC%2BD1MXkvFaqsrc%3D 19321416
44. Z Gao J Yin J Zhang, et al. 2009 Butyrate improves insulin sensitivity and increases energy expenditure in mice Diabetes 58 1509 1517 10.2337/db08-1637 1:CAS:528:DC%2BD1MXos1CqtbY%3D 19366864
45. JG Manns JM Boda 1967 Insulin release by acetate, propionate, butyrate, and glucose in lambs and adult sheep Am J Physiol 212 747 755 1:CAS:528:DyaF2sXktVyhtbo%3D 6024435
46. WR Wikoff AT Anfora J Liu, et al. 2009 Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites Proc Natl Acad Sci USA 106 3698 3703 10.1073/pnas.0812874106 1:CAS:528:DC%2BD1MXjt1Gksrk%3D 19234110
47. T Vilsboll JJ Holst 2004 Incretins, insulin secretion and type 2 diabetes mellitus Diabetologia 47 357 366 10.1007/s00125-004-1342-6 1:CAS:528: DC%2BD2cXis1Ggtrw%3D 14968296 (Pubitemid 38491230)
48. FK Knop T Vilsboll PV Hojberg, et al. 2007 Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state? Diabetes 56 1951 1959 10.2337/db07-0100 1:CAS:528:DC%2BD2sXos12qsro%3D 17513701 (Pubitemid 47195814)
49. LR Ranganath JM Beety LM Morgan JW Wright R Howland V Marks 1996 Attenuated GLP-1 secretion in obesity: cause or consequence? Gut 38 916 919 10.1136/gut.38.6.916 1:STN:280:DyaK2s7gsFCitw%3D%3D 8984033
50. E Rask T Olsson S Soderberg, et al. 2001 Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men Diabetes Care 24 1640 1645 10.2337/diacare.24.9.1640 1:CAS:528:DC%2BD3MXmvFKju74%3D 11522713
51. C Herrmann-Rinke A Voge M Hess B Goke 1995 Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides J Endocrinol 147 25 31 10.1677/joe.0.1470025 1:CAS:528:DyaK2MXotlKktb0%3D 7490533
52. RM Elliott LM Morgan JA Tredger S Deacon J Wright V Marks 1993 Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns J Endocrinol 138 159 166 10.1677/joe.0.1380159 1:CAS:528:DyaK3sXmt1Gjs7w%3D 7852887
53. C Qualmann MA Nauck JJ Holst C Orskov W Creutzfeldt 1995 Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose) Scand J Gastroenterol 30 892 896 10.3109/00365529509101597 1:CAS:528:DyaK2MXpsFaitL8%3D 8578189
54. NN Kok LM Morgan CM Williams MB Roberfroid JP Thissen NM Delzenne 1998 Insulin, glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide and insulin-like growth factor I as putative mediators of the hypolipidemic effect of oligofructose in rats J Nutr 128 1099 1103 1:CAS:528: DyaK1cXktlWhurs%3D 9649591
55. PD Cani C Knauf MA Iglesias DJ Drucker NM Delzenne R Burcelin 2006 Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor Diabetes 55 1484 1490 10.2337/db05-1360 1:CAS:528:DC%2BD28XksFahur8%3D 16644709 (Pubitemid 44195391)
56. PD Cani S Hoste Y Guiot NM Delzenne 2007 Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats Br J Nutr 98 32 37 10.1017/S0007114507691648 1:CAS:528:DC%2BD2sXosVOjs7s%3D 17367575 (Pubitemid 47272144)
57. PD Cani E Joly Y Horsmans NM Delzenne 2006 Oligofructose promotes satiety in healthy human: a pilot study Eur J Clin Nutr 60 567 572 10.1038/sj.ejcn. 1602350 1:CAS:528:DC%2BD28XjvF2luro%3D 16340949 (Pubitemid 43922875)
58. M Bose B Olivan J Teixeira FX Pi-Sunyer B Laferrere 2008 Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence? Obes Surg 19 217 229 10.1007/s11695-008-9696-3 18820978
59. B Laferrere J Teixeira J McGinty, et al. 2008 Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes J Clin Endocrinol Metab 93 2479 2485 10.1210/jc.2007-2851 1:CAS:528:DC%2BD1cXoslyktb8%3D 18430778 (Pubitemid 352008510)
60. B Laferrere S Heshka K Wang, et al. 2007 Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes Diabetes Care 30 1709 1716 10.2337/dc06-1549 1:CAS:528:DC%2BD2sXotlWhsbw%3D 17416796 (Pubitemid 47036341)
61. J Korner W Inabnet G Febres, et al. 2009 Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass Int J Obes (Lond) 33 786 795 10.1038/ijo.2009.79 1:CAS:528: DC%2BD1MXoslOhu7Y%3D
62. R Peterli B Wolnerhanssen T Peters, et al. 2009 Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial Ann Surg 250 234 241 10.1097/SLA.0b013e3181ae32e3 19638921
63. PD Cani R Bibiloni C Knauf, et al. 2008 Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice Diabetes 57 1470 1481 10.2337/db07-1403 1:CAS:528: DC%2BD1cXnsF2ju78%3D 18305141
64. EG Zoetendal M Rajilic-Stojanovic WM de Vos 2008 High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota Gut 57 1605 1615 10.1136/gut.2007.133603 1:CAS:528:DC%2BD1cXhtl2gtr%2FI 18941009